Combined prognostic impact of initial clinical stage and residual cancer burden after neoadjuvant systemic therapy in triple-negative and HER2-positive breast cancer: an analysis o... by Roberto A. Leon-Ferre, K. Dimitroff, C. Yau, K. V. Giridhar, R. Mukhtar, G. Hirst, N. Hylton, J. Perlmutter, A DeMichele, D Yee, L van ’t Veer, H Rugo, W. F. Symmans, M. P. Goetz, L. Esserman, J. C. Boughey

Get full text